[1]
Anawalt BD. Diagnosis and Management of Anabolic Androgenic Steroid Use. The Journal of clinical endocrinology and metabolism. 2019 Jul 1:104(7):2490-2500. doi: 10.1210/jc.2018-01882. Epub
[PubMed PMID: 30753550]
[2]
Higgins JP, Heshmat A, Higgins CL. Androgen abuse and increased cardiac risk. Southern medical journal. 2012 Dec:105(12):670-4. doi: 10.1097/SMJ.0b013e3182749269. Epub
[PubMed PMID: 23211503]
[3]
Penning R, Veldstra JL, Daamen AP, Olivier B, Verster JC. Drugs of abuse, driving and traffic safety. Current drug abuse reviews. 2010 Mar:3(1):23-32
[PubMed PMID: 20088818]
[4]
Dawson RT. Drugs in sport - the role of the physician. The Journal of endocrinology. 2001 Jul:170(1):55-61
[PubMed PMID: 11431137]
[5]
Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: a review. International journal of cardiology. 2010 Jun 25:142(1):8-14. doi: 10.1016/j.ijcard.2009.10.033. Epub 2009 Nov 17
[PubMed PMID: 19923015]
[6]
Graham MR,Davies B,Grace FM,Kicman A,Baker JS, Anabolic steroid use: patterns of use and detection of doping. Sports medicine (Auckland, N.Z.). 2008;
[PubMed PMID: 18489196]
[7]
Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of epidemiology. 2014 May:24(5):383-98. doi: 10.1016/j.annepidem.2014.01.009. Epub 2014 Jan 30
[PubMed PMID: 24582699]
Level 1 (high-level) evidence
[8]
Alquraini H, Auchus RJ. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions. Molecular and cellular endocrinology. 2018 Mar 15:464():28-33. doi: 10.1016/j.mce.2017.01.028. Epub 2017 Jan 24
[PubMed PMID: 28130115]
[9]
Iyer R, Handelsman DJ. Androgens. Frontiers of hormone research. 2016:47():82-100. doi: 10.1159/000445159. Epub 2016 Jun 27
[PubMed PMID: 27347677]
[10]
Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011 Aug:31(8):757-66. doi: 10.1592/phco.31.8.757. Epub
[PubMed PMID: 21923602]
Level 3 (low-level) evidence
[11]
Parkinson AB,Evans NA, Anabolic androgenic steroids: a survey of 500 users. Medicine and science in sports and exercise. 2006 Apr;
[PubMed PMID: 16679978]
Level 3 (low-level) evidence
[12]
Givens ML, Deuster PA. Androgens and Androgen Derivatives: Science, Myths, and Theories: Explored From a Special Operations Perspective. Journal of special operations medicine : a peer reviewed journal for SOF medical professionals. 2015 Fall:15(3):98-104. doi: 10.55460/8M1J-GJFL. Epub
[PubMed PMID: 26360363]
Level 3 (low-level) evidence
[13]
Kanayama G,Brower KJ,Wood RI,Hudson JI,Pope HG Jr, Anabolic-androgenic steroid dependence: an emerging disorder. Addiction (Abingdon, England). 2009 Dec;
[PubMed PMID: 19922565]
[15]
Fink J,Schoenfeld BJ,Hackney AC,Matsumoto M,Maekawa T,Nakazato K,Horie S, Anabolic-androgenic steroids: procurement and administration practices of doping athletes. The Physician and sportsmedicine. 2019 Feb;
[PubMed PMID: 30247933]
[16]
Christou MA, Christou PA, Markozannes G, Tsatsoulis A, Mastorakos G, Tigas S. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis. Sports medicine (Auckland, N.Z.). 2017 Sep:47(9):1869-1883. doi: 10.1007/s40279-017-0709-z. Epub
[PubMed PMID: 28258581]
Level 1 (high-level) evidence
[17]
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017 May 23:135(21):1991-2002. doi: 10.1161/CIRCULATIONAHA.116.026945. Epub
[PubMed PMID: 28533317]
[18]
Kam PC, Yarrow M. Anabolic steroid abuse: physiological and anaesthetic considerations. Anaesthesia. 2005 Jul:60(7):685-92
[PubMed PMID: 15960720]
[19]
Vanberg P, Atar D. Androgenic anabolic steroid abuse and the cardiovascular system. Handbook of experimental pharmacology. 2010:(195):411-57. doi: 10.1007/978-3-540-79088-4_18. Epub
[PubMed PMID: 20020375]
[20]
Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart (British Cardiac Society). 2004 May:90(5):496-501
[PubMed PMID: 15084541]
[21]
Christoffersen T, Andersen JT, Dalhoff KP, Horwitz H. Anabolic-androgenic steroids and the risk of imprisonment. Drug and alcohol dependence. 2019 Oct 1:203():92-97. doi: 10.1016/j.drugalcdep.2019.04.041. Epub 2019 Aug 1
[PubMed PMID: 31421475]
[22]
Ip EJ,Lu DH,Barnett MJ,Tenerowicz MJ,Vo JC,Perry PJ, Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012 Oct;
[PubMed PMID: 23033230]
[23]
Kanayama G, Hudson JI, DeLuca J, Isaacs S, Baggish A, Weiner R, Bhasin S, Pope HG Jr. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem. Addiction (Abingdon, England). 2015 May:110(5):823-31. doi: 10.1111/add.12850. Epub 2015 Feb 25
[PubMed PMID: 25598171]
[24]
Rasmussen JJ, Selmer C, Østergren PB, Pedersen KB, Schou M, Gustafsson F, Faber J, Juul A, Kistorp C. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PloS one. 2016:11(8):e0161208. doi: 10.1371/journal.pone.0161208. Epub 2016 Aug 17
[PubMed PMID: 27532478]
Level 2 (mid-level) evidence
[25]
Kanayama G, Pope HG, Hudson JI. Associations of anabolic-androgenic steroid use with other behavioral disorders: an analysis using directed acyclic graphs. Psychological medicine. 2018 Nov:48(15):2601-2608. doi: 10.1017/S0033291718000508. Epub 2018 Mar 1
[PubMed PMID: 29490719]
[26]
Ha ET,Weinrauch ML,Brensilver J, Non-ischemic Cardiomyopathy Secondary to Left Ventricular Hypertrophy due to Long-term Anabolic-androgenic Steroid Use in a Former Olympic Athlete. Cureus. 2018 Sep 17
[PubMed PMID: 30473946]
[27]
Akbari Z, Esmailidehaj M, Avarand E, Shariati M, Pourkhalili K. Ischemic Preconditioning Efficacy Following Anabolic Steroid Usage: A Clear Difference Between Sedentary and Exercise-Trained Rat Hearts. Cardiovascular toxicology. 2019 Aug:19(4):287-296. doi: 10.1007/s12012-018-9497-4. Epub
[PubMed PMID: 30535662]
[28]
Chistiakov DA,Myasoedova VA,Melnichenko AA,Grechko AV,Orekhov AN, Role of androgens in cardiovascular pathology. Vascular health and risk management. 2018
[PubMed PMID: 30410343]
[29]
Vlad RA, Hancu G, Popescu GC, Lungu IA. Doping in Sports, a Never-Ending Story? Advanced pharmaceutical bulletin. 2018 Nov:8(4):529-534. doi: 10.15171/apb.2018.062. Epub 2018 Nov 29
[PubMed PMID: 30607326]
[30]
Ganson KT, Cadet TJ. Exploring Anabolic-Androgenic Steroid Use and Teen Dating Violence Among Adolescent Males. Substance use & misuse. 2019:54(5):779-786. doi: 10.1080/10826084.2018.1536723. Epub 2018 Dec 21
[PubMed PMID: 30572768]
[31]
Guzzoni V, Selistre-de-Araújo HS, Marqueti RC. Tendon Remodeling in Response to Resistance Training, Anabolic Androgenic Steroids and Aging. Cells. 2018 Dec 7:7(12):. doi: 10.3390/cells7120251. Epub 2018 Dec 7
[PubMed PMID: 30544536]
[32]
Collomp K, Buisson C, Gravisse N, Belgherbi S, Labsy Z, Do MC, Gagey O, Dufay S, Vibarel-Rebot N, Audran M. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender. Endocrine. 2018 Mar:59(3):538-546. doi: 10.1007/s12020-017-1514-z. Epub 2018 Jan 10
[PubMed PMID: 29322301]
[33]
Fink J, Schoenfeld BJ, Nakazato K. The role of hormones in muscle hypertrophy. The Physician and sportsmedicine. 2018 Feb:46(1):129-134. doi: 10.1080/00913847.2018.1406778. Epub 2017 Nov 25
[PubMed PMID: 29172848]